(Philadelphia, PA) - Sarah J. Ratcliffe, PhD, has been named Assistant Professor in the Department of Biostatistics and Epidemiology at the University of Pennsylvania School of Medicine.

After earning her BS(Hons) degree in 1996 from the University of Technology in Sydney, Australia, Dr. Ratcliffe went on to receive her PhD from Macquarie University, also in Sydney, Australia. Her postdoctoral fellowship was completed at the University of Pennsylvania School of Medicine in the Department of Biostatistics and Epidemiology. She is also a former Statistical Consultant for The Statistical Laboratory, Macquarie Research Ltd., in Australia.

Dr. Ratcliffe's research interests focus on functional data analysis (models for complex curves) and the analysis of longitudinal data with informative dropout, specifically joint models for longitudinal and survival data. Her collaborative areas of research include reproductive and women's health, such as the use of fetal heart tracings in predicting adverse birth outcomes and later infant development.

Dr. Ratcliffe is a member of the American Statistical Association and the Statistical Society of Australia. She has been the recipient of numerous awards and honors including the Vice-Chancellor's Commendation for a Doctoral Thesis of Exceptional Merit and the 2002 Travel Award from the Eastern Northern American Region/International Biometric Society to attend the "Workshop for Junior Researchers" in Washington, DC.

She has been invited to lecture on several occasions including most recently at the Biostatistics Applied Research Forum at the University of Pennsylvania, where she discussed a random pattern-mixture model for longitudinal data with dropouts. Dr. Ratcliffe has also authored or co-authored research papers in publications including Statistics in Medicine and the 2001 Proceedings of the American Statistical Association Biometrics Section.


# # #

.

Penn Medicine is one of the world’s leading academic medical centers, dedicated to the related missions of medical education, biomedical research, excellence in patient care, and community service. The organization consists of the University of Pennsylvania Health System and Penn’s Raymond and Ruth Perelman School of Medicine, founded in 1765 as the nation’s first medical school.

The Perelman School of Medicine is consistently among the nation's top recipients of funding from the National Institutes of Health, with $550 million awarded in the 2022 fiscal year. Home to a proud history of “firsts” in medicine, Penn Medicine teams have pioneered discoveries and innovations that have shaped modern medicine, including recent breakthroughs such as CAR T cell therapy for cancer and the mRNA technology used in COVID-19 vaccines.

The University of Pennsylvania Health System’s patient care facilities stretch from the Susquehanna River in Pennsylvania to the New Jersey shore. These include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Lancaster General Health, Penn Medicine Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, founded in 1751. Additional facilities and enterprises include Good Shepherd Penn Partners, Penn Medicine at Home, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.

Penn Medicine is an $11.1 billion enterprise powered by more than 49,000 talented faculty and staff.

Share This Page: